Selenium in critically ill patients with systemic inflammatory response;Selenio en los pacientes críticos con respuesta inflamatoria sistémica

Nutricion Hospitalaria

Volumn 22, Issue 3, 2007, Pages 295-306

  Manzanares Castro, William ^a,b  

^a UNIVERSIDAD DE LA REPÚBLICA   (Uruguay)

^b HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

Antioxidants; Critically ill patient; Inflammatory response; Oxidative stress; Selenium

Indexed keywords

C REACTIVE PROTEIN; GLUTATHIONE; GLUTATHIONE PEROXIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; ISOENZYME; SELENIUM; SELENOCYSTEINE; SELENOMETHIONINE; SELENOPROTEIN P; THIOBARBITURIC ACID REACTIVE SUBSTANCE; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

APACHE; BLOOD LEVEL; BURN; CLINICAL TRIAL; CONTINUOUS INFUSION; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG MEGADOSE; HUMAN; INFECTION; INJURY; LENGTH OF STAY; LIPID PEROXIDATION; METABOLISM; MONOTHERAPY; MORTALITY; MULTIPLE ORGAN FAILURE; OXIDATIVE STRESS; PANCREATITIS; PROGNOSIS; PROTEIN FUNCTION; REVIEW; SEPSIS; SUPPLEMENTATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

CRITICAL ILLNESS; DIETARY SUPPLEMENTS; HUMANS; NUTRITIONAL STATUS; OXIDATIVE STRESS; SELENIUM; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 34249986684     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: None     Document Type: Review

References (87)

1. Kaim W. & Schwederesky B: Biological functions of the nonmetallic inorganic elements. En: Kaim W (Ed) Bioinorganic Chemistry: Inorganic Elements in the Chemistry Of Life. NY, John Wiley 1994; 318-9.
2. Korlhe J, Brigelius-Flohé R, Bock A, Gaertner R, Meyer O, Flohé L: Selenium in biology. Biol Chem 2000; 381:849-864.
3. Dodig S. & Cepelak I: The facts and controversies about selenium. Acta Pharm 2004; 54:261-76.
4. Forceville X: Selenium and the free electron. Intensive Care Med 2001; 27:16-8.
5. Demling RH. & De Biasse MA: Micronutrients in critical illness. Crit Care Clin 1995; 11:651-73.
6. a Ed. Saunders, Philadelphia 2001: 60-79.
7. Herr DL: Trace elements. En: Nutrition in critical care. Zaloga G (Ed). Mosby, St Louis; 1994; 261-76.
8. Neve J: New approaches to asses selenium status and requirement. Nut Rev 2000; 58:363.
9. Rayman MP: The importance of selenium to human health. The Lancet 2000; 356:233-41.
10. Néve J: Selenium as a nutraceutical: how to conciliate physiological and supranutritional effects for an essential trace element. Current Opinion in Nutrition and Metabolic care 2002; 5:659-63.
11. Prelack K. & Sheridan RL: Micronutrient supplementation in the critically ill patient: strategies for clinical practice. J Trauma 2001; 51:601-20.
12. Shenkin A: Micronutrients in the severely -injured patient. Proc Nutr Soc 2000; 59:451-6.
13. Shenkin A: The key role of micronutrients. Clin Nutr 2006; 25:1-13.
14. Schwarz K. & Foltz CM: Selenium is an integral part of factor 3 against dietary necrotic liver degeneration. J Amer Chem Soc 1957; 79:3292.
15. Schwarz K: Carácter esencial funciones metabólicas del Selenio. Clínicas Médicas de Norteamérica, 1976; 60:745-57.
16. Burk RF: Selenium: recent clinical advances. Current Opinion in Gastroenterology 2001; 17:162-6.
17. Xia Y, Hill KE, Byrne DW, Xu J, Burk RF: Effectiveness of selenium supplements in a low-selenium area of China. Am J Clin Nutr 2005; 81:829-34.
18. Reid ME, Stratton MS, Lilico AJ y cols.: A report of high dose selenium supplementation: response and toxixities. J Trace Elem Med Biol 2004; 18:69-74.
19. Hardy G. & Hardy I: Selenium: The Se-XY nutraceutical. Nutrition 2004; 20:590-3.
20. Schomburg L, Schweizer U, Kohrle J: Selenium and seleno-proteins in mammals: extraordinary, essential, enigmatic. Cell Mol Life Sci 2004; 61:1988-95.
21. Burk RF & Hill KE: Selenoprotein P: an extracelular protein with unique physical characteristics and a role in selenium homeostasis. Annu Rev Nutr 2005; 25:215-35.
22. Ají-Michael P & Vincent JL: The importance of being Selenium. Crit Care Med 1998; 26:1478-9.
23. Geoghean M, McAuley D, Eaton S, Powell-Tuck J: Selenium in critical illness. Curr Opin Crit Care 2006; 12:136-41.
24. Angstwurm MWA. & Gaertner R: Practicalities of selenium supplementation in critically ill patients. Curr Opin Clin Nutr Metab Care 2006; 9:233-8.
25. Venardos K, Harrison G, Headrick J, Perkins A: Effects of dietary selenium on glutathione Peroxidase and thioredoxin reductase activity and recovery from cardiac ischemia-reperfusion. J Trace Elements Med Biol 2004; 18:81-8.
26. Zachara BA, Salak A, Koterska D, Manitius J, Wasowicz W: Selenium and Glutathione Peroxidase in blood of patients with different stages of chronic renal failure. J Trace Elem Med Biol 2004; 17:291-9.
27. Wereszczzynska-Siemiatkowska U, Mroczko B, Siemiatkowski A, Szmitkowski M, Borawska M, Kosel J: The importance of Interleukin 18, Glutathione Peroxidase and Selenium concentration changes in acute pancreatitis. Digestive Diseases and Sciences 2004; 49:642-50.
28. Mostert V: Selenoprotein P: properties, functions, and regulation. Arch Biochem Biophys 2000; 376; 433-8.
29. Flohé L, Andressen JR, Brigelius-Flohé R, Maiorino M, Ursini F: Selenium, the element of the moon in life on earth. IUBMB Life 2000; 49:411-20.
30. Berger MM, Reymond MJ, Shenkin A y cols.: Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial. Intensive Care Med 2001; 27:91-100.
31. Angstwurm MWA, Schopohl J, Gaertner R: Selenium substitution has no direct effect on thyroid hormone metabolism in critically ill patients. European Journal of Endocrinology 2004; 151:47-54.
32. Koehrle J, Jakob F, Contempré B, Dumont JE: Selenium, the thyroid and the endocrine system. Endocr Rev 2005; 26:944-84.
33. Klein EA: Selenium: epidemiology and basic science. Journal of Urology 2004; 171:S50-S53.
34. Hawker FH, Stewart PM, Snitch PJ: Effects of acute illness on selenium status. Crit Care Med 1990; 18:442-46.
35. Berger MM, Cavadini C, Chiolero R y cols.: Cooper, Selenium, and Zinc status and balances after major trauma. J Trauma 1996; 40:103.
36. Forceville X, Vitoux D, Gauzit R, Combes A, Lahilaire P, Chappuis P: Selenium, systemic immune response syndrome, sepsis and outcome in critically ill patients. Crit Care Med 1998; 26:1536-44.
37. Maehira F, Luyo GA, Miyagi I y cols.: Alterations of serum selenium concentrations in the acute phase of pathological conditions. Clin Chem Acta 2002; 316:137-46.
38. Forceville X. & Vitoux D: Nutrition et sepsis. Nutrition Clinique et Métabolisme 1999; 13:177-86.
39. Berger MM: Can oxidative damage be treated nutritionally? Clin Nutr 2005; 24:172-83.
40. Berger MM. & Chioléro R: Apport d'antioxydants en reanimation: pourquoi, lesquels, avec quells objectifs? Réanimation 2001; 10:527-34.
41. Berger MM, Cavadini C, Bart A: Selenium losses in 10 burn patients. Clin Nutr 1992; 11:75-82.
42. Duffield AJ, Thomson CD, Hill KE, Williams S: An estimation of selenium requirements for New Zealanders. Am J Clin Nutr 1999; 70:896-903.
43. Gartner R, Albrich W, Angsstwurm WA: The effect of a selenium supplementation on the outcome of patients with severe systemic inflammation, burn and trauma. BioFactors 2001; 14:199-204.
44. Opal SM: Selenium replacement in severe systemic inflammatory response syndrome. Crit Care Med 1999; 27:2042-3.
45. Brown KM, Pickard K, Nicol F, Beckett GJ, Duthie GG, Arthur JR: Effects of organic and inorganic selenium supplementation on selenoenzyme activity in blood lymphocytes, granulocytes, platelets and erythrocytes. Clinical Science 2000; 98: 593-9.
46. Lovat R. & Preiser JC: Antioxidant therapy in intensive care. Curr Opin Crit Care 2003; 9:266-70.
47. Beck MA, Levander OA, Handy J: Oxidative stress mediated by trace elements. J Nutr 2003; 133:1463S-1467S.
48. Zazzo JF: Oxidative stress during acute inflammatory and critical states: implications for clinical practice. Nutrition Clinique et Métabolisme 2002; 16:268-74.
49. Víctor VM, Rocha M, Esplugues JV, De la Fuente M: Role of free radicals in sepsis: antioxidant therapy. Current Pharmaceutical Design 2005; 11:3141-58.
50. Berger MM: Manipulations nutritionnelles du stress oxydant: état des connaissances. Nutrition Clinique et Métabolisme 2006; 20:48-53.
51. Goodyear-Bruch C. & Pierce JD: Oxidative stress in critically ill patients. American Journal of Critical Care 2002; 11:543-51.
52. Fontaine E, Barnoud D, Schwebel C, Leverve X: Place des anti-oxydants dans la nutrition du patients septique. Réanimation 2002; 11:411-20.
53. Bulger EM. & Maier RV: Antioxidants in critical illness. Arch Surg 2001; 136:1201-7.
54. Coleman NA: Antioxidants in critical care medicine. Environmental Toxicology and Pharmacology 2001; 10:183-8.
55. Cutteridge JM, Mitchell J: Redox imbalance in the critically ill. Br Med Bull 1999; 179:99-110.
56. Metnitz PG, Bartens C, Fischer M, Fridrich P, Steltzer H, Druml W: Antioxidants status in patients with acute respiratory distress syndrome. Intensive Care Med 1999; 25:180-5.
57. Crimi E, Sica V, Williams-Ignaro S y cols.: The role of oxidative stress in adult critical care. Free Radical Biology & Medicine 2006; 40:398-406.
58. Roth E, Manhart N, Wessner B: Assessing the antioxidant status in critically ill patients. Curr Opin Clin Nutr Metab Care 2004; 7:161-8.
59. Maehira F, Miyagi I, Eguchi Y: Selenium regulates transcription factor NF-kB activation during the acute phase reaction. Clin Chem Acta 2003; 334:163-71.
60. Holmes-McNary M: Nuclear factor kappa B signaling in catabolic disorders. Curr Opin Clin Nutr Metab Care 2002; 5:255-63.
61. Zhang F, Yu W, Hargrove JL y cols.: inhibition of TNF-α induced ICAM-1, VCAM-1 and E-selectin expression by selenium. Atherosclerosis 2002; 161:381-6.
62. Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 2002; 30:11782-6.
63. Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H: Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 2003; 31:1048-52.
64. Agay D, Anderson RD, Sandre C y cols.: Alterations of antioxidant trace elements (Zn, Se, Cu) and related metaloenzymes in plasma and tissues following burn injury in rats. Burns 2005; 31:336-71.
65. Sandre C, Agay D, Ducros V y cols.: Early evolution of Selenium status and oxidative stress parameters in rat models of thermal injury. J Trace Elem Med Biol 2004; 17:313-8.
66. Berger MM, Shenkin A, Revelly JP y cols.: Cooper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004; 80:410-6.
67. Manzanares W, Torre MH, Biestro A y cols.: Serum Selenium concentration and Glutathione Peroxidase activity in Systemic Inflammatory Response and Multiple Organ Dysfunction Syndromes. Metal ions in Biology and Medicine 2006; 9:535-9.
68. Manzanares W, Torre MH, Biestro A, Mañay N, Pittini G, Facchin G: Selenium concentration and Glutathione Peroxidase activity in Systemic Inflammatory Response. Revista Brasileira de Medicina 2006; 63:144.
69. Heyland DK, Dhaliwal R, Suchner U, Berger MM: Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intensive Care Med 2005; 31:327-37.
70. Schrauzer GN: Selenomethionine: a review of its nutritional significance, metabolism and toxicity. J Nutr 2000; 130:1653-6.
71. Berger MM, Spertini F, Shenkin C y cols.: Trace element supplementation modulates pulmonary infection rates after major burns: a double blind, placebo controlled trial. Am J Clin Nutr 1998; 68:365-71.
72. Angstwurm MA, Schottdorf J, Schopohl J, Gaertner R: Selenium replacement in patients with severe systemic inflammatory response syndrome improves clinical outcome. Crit Care Med 1999; 27:1807-13.
73. Porter JM, Ivatury RR, Azimuddin K, Swami R: Antioxidant Therapy in the prevention of organ dysfunction syndrome and infectious complications after trauma: early results of a prospective randomized study. Am Surgeon 1999; 65:478-83.
74. Kazda A, Brodska H, Valenta J y cols.: Selenium and its substitution in critically ill patients. Crit Care 2006; S79-86.
75. Angstwurm MWA & Gaertner R: Selenium substitution in patients with severe sepsis as useful additive? Preliminary results of the SIC study. Intensive Care Med 2005; 31:84.
76. Mishra V, Baines M, Perry S y cols.: Selenium supplementation and outcome in septic ICU patients. Clin Chem Acta 2005; 355 (Supl.):S45-S46.
77. Yamaguchi T, Sano K, Takakura K y cols.: Ebselen in acute ischemic stroke: a controlled, double blind clinical trial. Ebselen Study Group. Stroke 1998; 29:12-7.
78. Saito I, Asano T, Sano K y cols.: Neuroprotective effect of an antioxidant Ebselen in patients with delayed neurological deficits after aneurysmal Subarachnoid Hemorrhage. Neurosurgery 1998; 42:269-77.
79. Otzurk C, Avlan D, Cinel I y cols.: Selenium pretreatment prevents bacterial translocation in rat intestinal ischemia reperfusion model. Pharmacol Res 2002; 46:171-5.
80. Berger MM, Baines M, Chioléro RL, Wardle CA, Cayeux C, Shenkin A: Influence of early trace element and vitamin E supplements on antioxidant status after major trauma: a controlled trial. Nutr Res 2001; 21:41-54.
81. Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P and the Canadian Critical Care Clinical Practice Guidelines Committee. Canadian Clinical Practice Guidelines for Nutrition Support in Mechanically Ventilated, Critically Ill Adult Patients. JPEN 2003; 27:355-73.
82. Dhaliwal R. & Heyland DK: Nutrition and infection in the Intensive Care Unit: what does the evidence show? Curr Opin Crit Care 2005; 11:461-267.
83. Nathens AB, Neff MJ, Jurkovich GJ y cols.: Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg 2002; 236;814-22.
84. Avenell A, Noble DW, Barr J, Engelhardt T: Selenium supplementation for critically ill adults. Cochrane Database Syst Rev 2006; 2:1-19.
85. ASPEN Board of Directors and The Clinical Guidelines Task Force. JPEN 2002; 26, Supl. 1:S88-S90.
86. Kreymann KG, Berger MM, Deutz NEP y cols.: ESPEN Guidelines on Enteral Nutrition: intensive care. Clin Nutr 2006; 25:210-23.
87. Terada A, Yoshida M, Seko Y y cols.: Active oxygen species generation and cellular damage by additives of parenteral preparations: selenium and sulfhydril compounds. Nutrition 1999; 15:651-5.